Impact of Sirolimus-Eluting and Paclitaxel-Eluting Stents on Outcome in Patients With Diabetes Mellitus and Stenting in More Than One Coronary Artery
Authors:
- Goran StankovicGSGoran Stankovic
- John CosgraveJCJohn Cosgrave
- Alaide ChieffoACAlaide Chieffo
- Ioannis IakovouIIIoannis Iakovou
- Giuseppe SangiorgiGiuseppe Sangiorgi
- Matteo MontorfanoMMMatteo Montorfano
- Flavio AiroldiFAFlavio Airoldi
- Mauro CarlinoMCMauro Carlino
- Iassen MichevIMIassen Michev
- Leo FinciLFLeo Finci
- Antonio ColomboACAntonio Colombo
- 1 August 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 98 (3) , 362-366
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary RevascularizationNew England Journal of Medicine, 2005
- Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic PatientsNew England Journal of Medicine, 2005
- Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting StentsJAMA, 2005
- Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitusJACC, 2005
- Diabetes and Coronary RevascularizationJAMA, 2005
- Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarctionJACC, 2005
- A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiologyJACC, 2005
- Impact of Sirolimus-Eluting Stents on Outcome in Diabetic PatientsCirculation, 2004
- Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term resultsJACC, 2004
- Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic PatientsCirculation, 2004